UMeWorld Inc.

What they do

The company exited the education business in 2021 and repositioned around diacylglycerol (DAG)-based cooking oil and related functional nutrition products sold under the DAGola brand. Products are sold primarily through online marketplace platforms and direct-to-consumer channels in the United States. DAG oil is sourced from a strategic manufacturing partner in China, and the company uses third-party manufacturers, co-packers, and fulfillment providers in a capital-light model. Asia-Pacific activity runs through Dagola Hong Kong Limited and its subsidiary Guangzhou Duokanglong Special Medical Nutrition Technology Co., Ltd. in Mainland China.

Revenue drivers

• PRC distributor channel — The June 30, 2026 quarter's $540,359 of revenue was attributed primarily to sales through the PRC subsidiary following late-2025 market entry, making it the dominant contributor.
• U.S. online marketplace / DTC (DAGola) — Sales through the Amazon marketplace and direct-to-consumer channels in the United States; the company stated U.S. revenue was nominal in the June 2026 quarter.
• Hong Kong regional holding / China commercialization — Dagola Hong Kong Limited acts as regional holding entity supporting the Mainland China subsidiary's regulatory compliance, distribution development, and early-stage commercialization.

Recent performance

Revenue for the three months ended June 30, 2026 was $540,359 versus $341 a year earlier, driven by PRC distributor sales. Cost of revenues was $497,542 against $1,743, producing gross profit of $42,817 versus a prior-year gross loss of $1,402. Selling, general and administrative expenses rose to $135,712 from $19,484, tied to executive compensation, investment banking, financial advisory, legal, accounting and compliance costs, and business development for Project Verdant. The quarter's net loss widened to $92,885 from $20,885, though quarterly revenue has risen each period from $1,275 (Sept 2025) to $147,455 (Dec 2025) to $351,187 (Mar 2026) to $540,359 (Jun 2026).

Strategy

Management's stated strategy is to expand distribution channels, increase product availability, and develop additional functional nutrition products. Recent investment has gone into corporate infrastructure, professional services, and market expansion initiatives, including Project Verdant. The company completed its redomiciliation from the British Virgin Islands to Delaware on October 2, 2025 and transitioned from a foreign private issuer to a U.S. domestic issuer. It continues to build its Asia-Pacific segment through Hong Kong and Mainland China subsidiaries while describing operations as capital-light.

Risks

• Weak balance sheet and accumulated losses — At June 30, 2026 total liabilities of $1.8M exceeded total assets of $1.5M, with shareholder equity of negative $306,312 and only $86,259 of cash and equivalents.
• Revenue concentration in a nascent PRC channel — The June 2026 quarter's revenue came primarily from PRC distributor activity following initial market entry in late 2025, so results depend on a channel with little operating history.
• Severe negative operating cash flow — Operating cash flow was negative in each year from 2021 through 2025, including -$113,946 in fiscal 2025, while net losses persisted every year over that span.
• Listing and reporting disruptions — The company received a delisting notice or listing-rule failure on January 21, 2026 and changed accountants twice within a month, on January 5 and February 6, 2026.

Outlook

Management points to continued distributor channel activity in the PRC following late-2025 market entry and to continued expansion of sales and distribution in the Asia-Pacific region through its Hong Kong and China subsidiaries. It states plans to broaden distribution, raise product availability, and develop additional functional nutrition products. The June 2026 quarter showed revenue growth but also a wider net loss as spending on infrastructure, professional services, and market expansion increased. The company notes it operates a capital-light model relying on third-party manufacturing, packaging, and fulfillment.